kr279.00
1.90% yesterday
Stockholm, Nov 21, 05:30 pm CET
ISIN
SE0010323311
Symbol
BIOA B

BioArctic AB Stock price

kr279.00
-21.40 7.12% 1M
+73.60 35.83% 6M
+79.50 39.85% YTD
+93.60 50.49% 1Y
-17.60 5.93% 3Y
+185.70 199.04% 5Y
+250.00 862.07% 10Y
+250.00 862.07% 20Y
Stockholm, Closing price Fri, Nov 21 2025
-5.40 1.90%
ISIN
SE0010323311
Symbol
BIOA B
Industry

Key metrics

Basic
Market capitalization
kr25.2b
Enterprise Value
kr23.4b
Net debt
positive
Cash
kr1.9b
Shares outstanding
88.6m
Valuation (TTM | estimate)
P/E
24.7 | 23.9
P/S
13.2 | 12.2
EV/Sales
12.2 | 11.3
EV/FCF
21.4
P/B
12.8
Dividends
DPS
kr0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 0.0%
Increased
0 Years
Financials (TTM | estimate)
Revenue
kr1.9b | kr2.1b
EBITDA
kr1.2b | kr1.2b
EBIT
kr1.2b | kr1.2b
Net Income
kr999.7m | kr1.1b
Free Cash Flow
kr1.1b
Growth (TTM | estimate)
Revenue
1,046.5% | 699.3%
EBITDA
- | 673.7%
EBIT
563.1% | 636.2%
Net Income
529.3% | 696.5%
Free Cash Flow
775.0%
Margin (TTM | estimate)
Gross
97.1%
EBITDA
61.7% | 59.0%
EBIT
61.2%
Net
52.2% | 51.4%
Free Cash Flow
56.9%
Financial Health
Equity Ratio
80.5%
Return on Equity
-19.8%
ROCE
58.6%
ROIC
-
Debt/Equity
0.0
More
EPS
kr11.3
FCF per Share
kr12.3
Short interest
-
Employees
107
Rev per Employee
kr2.4m
Show more

Is BioArctic AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.

BioArctic AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a BioArctic AB forecast:

8x Buy
80%
1x Hold
10%
1x Sell
10%

Analyst Opinions

10 Analysts have issued a BioArctic AB forecast:

Buy
80%
Hold
10%
Sell
10%

Financial data from BioArctic AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
1,916 1,916
1,047% 1,047%
100%
- Direct Costs 56 56
74% 74%
3%
1,860 1,860
1,279% 1,279%
97%
- Selling and Administrative Expenses 192 192
35% 35%
10%
- Research and Development Expense 388 388
81% 81%
20%
1,182 1,182
-
62%
- Depreciation and Amortization 9.68 9.68
-
1%
EBIT (Operating Income) EBIT 1,172 1,172
563% 563%
61%
Net Profit 1,000 1,000
529% 529%
52%

In millions SEK.

Don't miss a Thing! We will send you all news about BioArctic AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

BioArctic AB engages in the research and development of modifying treatments and diagnostics for neurodegenerative diseases. Its research areas are Alzheimer’s disease and Parkinson’s disease where there are large unmet medical needs. The company was founded by Lars Gunnar Lannfelt and Pär Lars Gellerfors on January 24, 2003 and is headquartered in Stockholm, Sweden.

Head office Sweden
CEO Gunilla Osswald
Employees 107
Founded 2000
Website www.bioarctic.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today